| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2088861
Max Phase: Preclinical
Molecular Formula: C9H11N3O2
Molecular Weight: 193.21
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cn1ccc2c1C(=O)NCC/C2=N\O
Standard InChI: InChI=1S/C9H11N3O2/c1-12-5-3-6-7(11-14)2-4-10-9(13)8(6)12/h3,5,14H,2,4H2,1H3,(H,10,13)/b11-7+
Standard InChI Key: RVQBJBPPCFJMMT-YRNVUSSQSA-N
Associated Targets(Human)
A549 127892 Activities
LoVo 4724 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PC-3 62116 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cyclin-dependent kinase 2/cyclin A 2220 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 193.21 | Molecular Weight (Monoisotopic): 193.0851 | AlogP: 0.34 | #Rotatable Bonds: 0 |
| Polar Surface Area: 66.62 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.50 | CX Basic pKa: 0.07 | CX LogP: -0.22 | CX LogD: -0.23 |
| Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.46 | Np Likeness Score: 0.23 |
References
| 1. White AW, Carpenter N, Lottin JR, McClelland RA, Nicholson RI.. (2012) Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine., 56 [PMID:22995819] [10.1016/j.ejmech.2012.08.022] |
Source
Source(1):